163 related articles for article (PubMed ID: 37982973)
1. Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder-related optic neuritis.
Yang Q; Lai C; Meng C; Chang Q; Wei N; Wang J
Neurol Sci; 2024 May; 45(5):2191-2197. PubMed ID: 37982973
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
[TBL] [Abstract][Full Text] [Related]
3. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica].
Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684
[No Abstract] [Full Text] [Related]
4. Clinical Course and Treatment Response of Neuromyelitis Optica Spectrum Disease: An 8-Year Experience.
Lin CW; Lin IH; Chen TC; Jou JR; Woung LC
Asia Pac J Ophthalmol (Phila); 2019; 8(3):206-210. PubMed ID: 30421588
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
[TBL] [Abstract][Full Text] [Related]
6. Late-Onset Neuromyelitis Optica Spectrum Disorder Mimicking a Non-Arteritic Anterior Ischemic Optic Neuropathy-Case Report.
Sedlak L; Swierczynska M; Promienska DW
Turk J Ophthalmol; 2023 Jun; 53(3):192-196. PubMed ID: 37345328
[TBL] [Abstract][Full Text] [Related]
7. Natural history of the visual impairment of relapsing neuromyelitis optica.
Merle H; Olindo S; Bonnan M; Donnio A; Richer R; Smadja D; Cabre P
Ophthalmology; 2007 Apr; 114(4):810-5. PubMed ID: 17141316
[TBL] [Abstract][Full Text] [Related]
8. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Collongues N; Marignier R; Jacob A; Leite MI; Siva A; Paul F; Zephir H; Akman-Demir G; Elsone L; Jarius S; Papeix C; Mutch K; Saip S; Wildemann B; Kitley J; Karabudak R; Aktas O; Kuscu D; Altintas A; Palace J; Confavreux C; De Seze J
Mult Scler; 2014 Jul; 20(8):1086-94. PubMed ID: 24323817
[TBL] [Abstract][Full Text] [Related]
9. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and long-term visual outcome of optic neuritis in neuromyelitis optica spectrum disorder: A comparison between Thai and American-Caucasian cohorts.
Vanikieti K; Poonyathalang A; Jindahra P; Bouzika P; Rizzo JF; Cestari DM
Mult Scler Relat Disord; 2017 Oct; 17():87-91. PubMed ID: 29055481
[TBL] [Abstract][Full Text] [Related]
11. Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
Pula JH; Kattah JC; Keung B; Wang H; Daily J
J Neurol Sci; 2014 Oct; 345(1-2):209-12. PubMed ID: 25125046
[TBL] [Abstract][Full Text] [Related]
12. A prospective case-control study comparing optical coherence tomography characteristics in neuromyelitis optica spectrum disorder- optic neuritis and idiopathic optic neuritis.
Zhao X; Qiu W; Zhang Y; Luo Y; Zhang X; Lu L; Yang H
BMC Ophthalmol; 2018 Sep; 18(1):247. PubMed ID: 30217177
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of optic neuritis in patients with relapsing neuromyelitis optica.
Papais-Alvarenga RM; Carellos SC; Alvarenga MP; Holander C; Bichara RP; Thuler LC
Arch Ophthalmol; 2008 Jan; 126(1):12-6. PubMed ID: 18195212
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis.
Kang H; Chen T; Li H; Xu Q; Cao S; Wei S
J Neurol; 2017 Oct; 264(10):2130-2140. PubMed ID: 28879451
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
Lai C; Tian G; Takahashi T; Liu W; Yang L; Zhang X
J Neuroophthalmol; 2011 Mar; 31(1):16-9. PubMed ID: 21150455
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
[TBL] [Abstract][Full Text] [Related]
17. Comparing evolvement of visual field defect in neuromyelitis optica spectrum disorder-optic neuritis and idiopathic optic neuritis: a prospective study.
Liang J; Zhang Y; Liu K; Xu X; Zhao X; Qiu W; Zhang X; Yang H
BMC Ophthalmol; 2022 Aug; 22(1):338. PubMed ID: 35945524
[TBL] [Abstract][Full Text] [Related]
18. [Effects of intravenous methylprednisolone pulse therapy on recurrent optic neuritis associated with aquaporin 4 antibody seropositive neuromyelitis optica].
Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):509-513. PubMed ID: 32842332
[No Abstract] [Full Text] [Related]
19. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders.
Mori S; Kurimoto T; Ueda K; Nakamura M
Jpn J Ophthalmol; 2018 Jul; 62(4):525-530. PubMed ID: 29802557
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis and neuromyelitis optica spectrum disorder: A conundrum.
Khurana R; Agrawal M; Mehta R; Shankar S
Rom J Ophthalmol; 2022; 66(3):277-280. PubMed ID: 36349166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
